Home  >  Press Releases  >  Most Recent
Share

Press Releases

Press release year list 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
November 14, 2011
RALEIGH, N.C.-Some ag student out there has a big idea about how to promote ag. The Reach Teach Learn Project will make it happen. Hundreds of youth study on ag college campuses every day, passionate about agriculture and ready to tell their story. The Reach Teach Learn Project provides a vehicle for students to channel that passion into advocacy for agriculture. In its fourth year, the Reach Teach Learn Project—sponsored by Pfizer Animal Health Global Poultry—helps aspiring poultry industry enthusiasts understand more concretely what it takes to produce safe, credible food for consumers. “All facets of agriculture, including the poultry industry, are impacted by consumer perceptions,” says Robbie Moody, Pfizer Global Poultry Regional Marketing Director. “Through the Reach Teach Learn Project we hope to create an opportunity for college ag students to open a dialogue with consumers that enables the creation of positive perceptions about the poultry products they buy.” In previous ...
November 8, 2011
KALAMAZOO, Mich.-Pfizer Animal Health affirmed its commitment to innovation in equine health with the opening today of the Pfizer Animal Health Equine Research Center in Richland, Mich. The center, the culmination of a $7 million investment, expands Pfizer Animal Health’s global research and development network headquarters in Kalamazoo, Mich., and will serve as the worldwide hub for research and development of equine vaccines and novel therapeutics. “The dedication of the Equine Research Center builds on the $75 million investment in the renovation and expansion of Pfizer’s veterinary medicine R&D headquarters in Kalamazoo completed in 2009,” said Dr. Cathy Knupp, Vice President, Veterinary Medicine Research and Development, Pfizer Animal Health. “The Center will support the work of a multi-disciplinary team of scientists committed to providing horse owners and the veterinarians who support them with truly innovative, best-in-class health solutions.” The Center adds 24,000 square ...
November 7, 2011
The benefits of in ovo vaccination are now within the reach of many more hatcheries worldwide, thanks to the development of a new compact device. Embrex* Inovoject* m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject. The new device allows these hatcheries to benefit from the improved accuracy, reliability and efficiency of in ovo vaccination, but in a more compact form. Full technical details for the new Inovoject m will be unveiled at the International Poultry Expo in Atlanta, Georgia in January 2012. According to Melinda Freson, senior manager, BioDevice Marketing, Pfizer Animal Health Global Poultry, the new device will include the same core features of the larger Inovoject in a more condensed package. “There has been a need for a smaller Inovoject for some time,” said Melinda Freson. “For smaller ...
November 3, 2011
JILIN-Pfizer Animal Health, a business unit of Pfizer (NYSE: PFE), and Jilin Guoyuan Animal Health Co., Ltd., announced today the establishment of the joint venture Jilin Pfizer Guoyuan Animal Health Co., Ltd . The joint venture, which has been granted a license by local Chinese government authorities, formalizes the strategic agreement signed on September 8 to develop, manufacture, and distribute animal vaccines in China. Terms of the agreement were not disclosed. The new company will focus initially on swine vaccine development and commercialization. In the future, it will consider new opportunities to offer Chinese livestock producers a comprehensive range of vaccine products to help protect the health of food production animals. “As Chinese society is becoming more affluent, demand for meat, especially pork, is rapidly increasing. A quality, affordable food supply begins with healthy animals,” said Juan Ramón Alaix, president, Pfizer Animal Health. “We believe Jilin Pfizer Guoyuan ...
October 18, 2011
Results of Ten-Year Partnership Show Increased Standard of Living in Poor, Rural Communities NEW YORK, N.Y., October 18 - Pfizer Animal Health and The Resource Foundation announced today the expansion of a comprehensive education and training program to increase the capacity, productivity and quality of life of rural farmers in eight Latin American countries.  Plans call for tailoring the program to the needs of rural communities in India.  The agreement was guided by results of a decade-long collaboration also announced today. Pfizer Animal Health and the Pfizer Foundation have committed $460,000 in 2011 to this program, which will involve more than 3,000 farmers and their families in Argentina, Brazil, Chile, Colombia, Costa Rica, Guatemala, Mexico and Peru as well as 7,250 farmers and their families through the program’s expansion to India’s Madhya Pradesh, Mathura, Orissa, Uttar Pratesh, and Rajasthan states. Improving animal health is crucial in rural communities where farming is ...
October 13, 2011
MADISON, N.J.-Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and other professionals raising pork, beef and dairy animals. Presented by Pfizer Animal Health, Veterinarians On Call premiered in September on channel YouTube.com/VetsOnCall or YouTube.com/VeterinariansOnCall. “We as veterinarians and farmers have great stories to tell of the care we provide to animals on the farm,” said veterinarian Dr. Paul Ruen of Fairmont, Minn., immediate past president of the American Association of Swine Veterinarians (AASV), one of five veterinarians who volunteered to host a film crew on his job. “I am proud to explain that I wear several ...
September 8, 2011
MADISON, N.J., & HUINAN, China-Pfizer Animal Health, a business unit of Pfizer Inc. (NYSE: PFE), and Jilin Guoyuan Animal Health Company, Ltd., an innovator in animal health vaccines based in Huinan, today announced an agreement to jointly develop, manufacture and distribute animal health vaccines in China. The new joint venture, Jilin Pfizer Guoyuan Animal Health Co., Ltd., will bolster the capabilities of both companies to offer a comprehensive range of vaccine products tailored to help China’s livestock producers meet increasing demand for a safe and abundant supply of pork, beef, dairy, and poultry from healthy animals. The animal vaccine market in China is valued at $800 million per year. Pfizer Guoyuan Animal Health will focus initially on developing vaccines to protect the health of swine. Vaccines for swine have high growth potential as China is the world’s leading pork producing nation, with an annual population of more than 600 million pigs. The joint venture provides a ...
July 7, 2011
Pfizer to Continue to Enhance the Value of its Established Products and Consumer Healthcare Businesses Within the Company, While Continuing to Strengthen its Biopharmaceutical Core NEW YORK-Pfizer Inc. (NYSE: PFE) today announced that it is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value. The company is considering options that may include, among others, a full or partial separation of each of these businesses from Pfizer through a spin-off, sale or other transaction. Given the separate and distinct nature of Animal Health and Nutrition, the company may pursue a different strategic alternative for each business. “Both Animal Health and Nutrition are strong businesses with attractive customer bases and solid fundamentals, but distinct enough from our core businesses that their value may be best maximized outside the company,” said Ian ...
June 22, 2011
Brussels-Click below to read the IFAH Press Release Alejandro Bernal Elected Chairman of International Federation for Animal Health - Europe ...
June 8, 2011
Madison, N.J.-Pfizer Inc.’s Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitroâ (Roxarsone), a feed medicine used primarily in poultry production. Pfizer is taking this action in response to a request by the U.S. Food and Drug Administration (FDA) based on a recent study by the Agency. This study used a new method of testing for very low levels of inorganic arsenic in poultry tissue. The study found that the use of 3-Nitro results in extremely low residue levels of inorganic arsenic in the liver of treated chickens but levels higher than those found in chickens raised without the product. This extremely low level is equivalent to the amount of inorganic arsenic found in an eight-ounce glass of drinking water. FDA agency officials stressed that there is no imminent public health risk from eating chicken treated with 3-Nitro. According to the FDA, even in the context of this recent data, there is no need for people to alter their consumption of chicken. ...
May 11, 2011
MADISON, NJ-Pfizer Animal Health and American Humane Association today announced a partnership to conduct a study on the impact of animal-assisted therapy on pediatric oncology patients, as well as on their parents, caregivers, siblings, and other close family members. The partnership — which includes a $282,000 grant from Pfizer and the Pfizer Foundation — exemplifies the strategic goal of both organizations to better quantify in clinical terms what many in health care already realize as the extraordinary power of the human-animal bond. “This important research will measure the impact of animal-assisted therapy on pediatric oncology patients and their families, thus furthering the fields of research on human-animal interaction and integrated therapies for conditions such as cancer in children,” said J. Michael McFarland, DVM, Diplomate ABVP and Group Director of Veterinary Medical Services & Corporate Citizenship for Pfizer Animal Health. “We are proud to be part of the work that ...
March 7, 2011
Durham, NC-Pfizer Poultry Health has introduced a broader, diversified portfolio of products and services with the acquisition of Alpharma LLC as part of Pfizer’s acquisition of King Pharmaceuticals. With the acquisition of Alpharma, Pfizer Poultry Health now offers a wider portfolio of products and services than any other global poultry healthcare provider. “The integration expands Pfizer Poultry Health’s product portfolio and broadens the range of healthcare solutions we can offer our poultry customers. It allows us to enter new therapeutic fields and deliver increased expertise to poultry producers,” said José Francisco Ortiz C., Vice President, Pfizer Poultry Health & New Established Brands. With this acquisition, Pfizer Poultry Health gains a portfolio of medicated feed additives, water-soluble therapeutics and probiotics and enters the poultry nutrition sector. These products complement Pfizer’s existing range of biologicals, pharmaceuticals and devices and establish Pfizer as a ...
January 28, 2011
RALEIGH, N.C.-Visitors to the VIV Asia 2011 exhibition in Bangkok in March will be able to see the new, expanded portfolio from Pfizer Poultry Health, including one of its fully automated in ovo injection devices. Though the company has a wide range of health solutions covering the major poultry production diseases, its focus is on the individual farm, says Hari Yethirajyam Prasad, Asia-Pacific Regional Marketing Director. “Our aim is to provide our customers with individual help and advice that is tailored specifically to their needs at an individual business or unit level. “We can do this because we have a huge amount of experience at the farm level, dealing with many different production systems with lots of different problems. “VIV Asia is a fantastic opportunity for us to showcase our extensive portfolio of vaccines, devices and pharmaceuticals to members of the industry from right across the Asia-Pacific region. But the reason why many producers come to us is the value that we ...
January 26, 2011
RALEIGH, N.C.-Pfizer Poultry Health is offering U.S. poultry producers a new option to optimize protection against one of the poultry industry’s most costly diseases, coccidiosis. Inovocox® EM1 is specially formulated to fight coccidiosis - the intestinal parasitic disease with an annual estimated global economic impact exceeding $3 billion. The new formulation accompanies the vaccine Inovocox® - launched in early 2009 - as the first and only coccidiosis vaccines specifically licensed and designed for in ovo administration. Both vaccines contain Eimeria acervulina and E. tenella but, unlike its relative, Inovocox EM1 contains only one strain of E. maxima, meaning there is a reduced risk of disturbing the enterocytes of the midgut and a lower incidence of necrotic enteritis. Inovocox EM1 is the optimal choice for environmental or management conditions that make it challenging for coccidiosis vaccines to be successful. “Pfizer Poultry Health created two distinct formulations with ...